Official Course
Description: MCCCD Approval: 3-24-2009 |
||
CRC120 2009 Summer I – 2012 Summer II |
LEC
4.0 Credit(s) 4.0 Period(s) 4.0 Load
Occ |
|
Introduction
to Clinical Research |
||
Introduction to the clinical research process. History,
development and basic study designs in varied health, biomedical and
biotechnical settings. Clinical trial development phases and regulatory
protection for human subjects. Roles and responsibilities of the clinical
research team and research organization. Good Clinical Practice (GCP) and
International Committee on Harmonization (ICH) guidelines. Functions,
research terminology, and general research funding of the Institutional
Review Board (IRB) and Ethics Review Committee. Prerequisites: None. |
||
Go to Competencies Go to Outline
MCCCD
Official Course Competencies: |
|
|
|
CRC120 2009 Summer
I - 2012 Summer II |
Introduction to Clinical Research |
1.
|
Define a minimum of 100 common research terms. (I) |
2.
|
Identify correct terminology for 50 research abbreviations
and acronyms. (I) |
3.
|
Explain the
regulatory progression of protection of human subjects in clinical research
as it relates to historical research events. (II) |
4.
|
Describe how the basic ethical principles of human subject
research are implemented under current federal regulations. (III) |
5.
|
List the major federal and state regulatory agencies governing
human subject research. (IV) |
6.
|
Identify professional research associations and their
respective roles. (IV) |
7.
|
Explain basic study designs for human subject research.
(V) |
8.
|
List the federally required and optional basic elements of
an informed consent form (ICF). (VI) |
9.
|
Identify the
major Code of Federal Regulations (CFR) sections that govern human subject
and clinical trial research. (VII) 10 Prepare a clinical research team
organizational chart. (VIII) 11 Define and roles and responsibilities of the
clinical research team as they relate to the clinical research process and
development phases I-IV. (VIII, IX) |
10.
|
Describe the roles and responsibilities of various
research organizations involved in the clinical research process. (X) |
11.
|
Compare and contrast the Good Clinical Practice (GCP) and
International Committee on Humanization (ICH) guidelines. (XI) |
12.
|
Summarize the developmental research phases
I-IVB. (XII) |
Go to Description Go to top of
Competencies
MCCCD
Official Course Outline: |
||
|
||
CRC120 2009 Summer
I - 2012 Summer II |
Introduction to Clinical Research |
|
|
||
I. Research Terminology and
Definitions A. Common Research
Definitions B. Abbreviations C. Acronyms D. Common Rule Definition
and Application E. Basic Ethical Research
Principles II. Human Subject Research
and Ethical Considerations A. Historical Case Studies B. President's Commission
for the Study of Ethical Problems in Medicine and Biomedical and Behavioral
Research C. National Commission for
the Protection of Human Subjects of Biomedical and Behavioral Research III. Development of Ethical
Research Principles, Regulations and Guidelines A. Nuremburg Code 1949 B. National Research Act
1974/81 (DHHS 45CFR46) C. Declaration of Helsinki
1975 D. Belmont Report 1979 E. FDA (21CFR50/56) IV. Development of
Institutional Review Boards and Data Safety Monitoring Boards A. Department of Health and
Human Services (DHHS) B. Office of Human Research
Protection (OHRP) - Federal Research Oversight C. Institutional Review Board
(IRB) 1. Roles 2. Responsibilities 3. Membership D. Data Safety Monitoring
Board (DSMB) 1. Roles 2. Responsibilities E. Clinical Research
Approval Processes 1. Types 2. Organizational structure
V. Basic Designs and
Formats of Human Subject Research A. Quantitative
methodologies B. Qualitative
methodologies C. Descriptive designs 1. Longitudinal 2. Cross-sectional 3. Other D. Correlational Designs 1. Predictive 2. Module testing 3. Other E. Quasi-experimental 1. Control group 2. Interrupted time series 3. Other F. Experimental 1. Randomized 2. Factorial 3. Crossover 4. Other G. Non-traditional 1. Primary prevention 2. Health promotion 3. Meta-analysis VI. Informed Consent
Regulations A. Federal and
International Regulations B. Required Elements of
Informed Consent Form (ICF) C. Local IRB Sample
Wording/Requirements D. Grade Level Wording E. Examples 1. Correct ICF 2. Incorrect ICF VII. Roles and
Responsibilities of Federal and State Regulatory Agencies for Research A. Office of Inspector
General B. Office of Human Research
Protections C. National Institutes of
Health/ Department of Health & Human Services D. Federal Drug Agency E. State Applicable
Regulations VIII. Research Team A. Team Members 1. Principal Investigator
(PI) 2. Co-PI 3. Sub-PI 4. Medical Officer/Writer 5. Clinical Research
Coordinator (CRC) 6. Technicians 7. Research Pharmacist a. Statistician b. Regulatory manager
(monitor/auditor) 8. Data Manager 9. Scientific Writer/Publisher
B. Roles and
Responsibilities C. Organizational Structure
IX. Skills and Attributes
of the Clinical Research Professional A. Demeanor B. Knowledge and Experience
C. Communication Skills D. Attention to Detail E. Affiliation with
Professional Research Associations and Respective Roles 1. Society of Clinical
Research Associates 2. Association of Clinical
Research Professional 3. Drug Information
Association 4. Regulatory Affairs
Professional Society 5. Institutional Review Board
Forum-internet X. Roles and
Responsibilities of Research Organizations and Participants A. Pharmaceutical Companies
B. Biotech and Medical
Device Companies C. Contract Research
Organizations (CRO) D. Site Management
Organizations (SMO) E. Community Clinical
Oncology Programs (CCOPS) F. Data Safety Monitoring
Board (DSMB) G. Funding Entities H. Institutional Research
Organizations/Investigative Sites I. Research Subjects and
Significant Others J. Community K. Academic Institution L. Multi-sites M. Independent N. Cooperatives O. International P. Research Laboratories XI. Good Clinical Practice
(GCP) and International Committee on Harmonization (ICH) Guidelines A. Historical Development B. Guideline Review 1. GCP 2. ICH C. International verses US
Research Guideline Differences D. Standard Operating
Procedure Guidelines E. Current US &
International Issues XII. Clinical Trial
Development Phases A. Defining phases 1. Phase I – Phase IV 2. Post marketing B. New Drug Development and
Marketing Approval Process C. Special Development
Considerations 1. Drug 2. Device 3. Biologic 4. Radio-logic D. Clinical Trial
Originations 1. Federal 2. Sponsor 3. Principal Investigator 4. World Health
Organization |
|
|